IP Library Granted Patent US 8,404,826
Granted Patent B2
US 8,404,826 · App. 13/220,894 · Granted Mar 26, 2013

Mycobacterial antigens expressed under low oxygen tension

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,404,826
App. No.
13/220,894
Granted
Mar 26, 2013
Kind
B2
Abstract

A method is provided for identifying mycobacterial genes that are induced or up-regulated under continuous culture conditions defined by a dissolved oxygen tension of up to 10% air saturation measured at 37° C. when compared with a dissolved oxygen tension of at least 40% air saturation measured at 37° C. Said induced or up-regulated genes form the basis of nucleic acid vaccines, or provide targets to allow preparation of attenuated mycobacteria for vaccines against mycobacterial infections. Similarly, peptides encoded by said induced or up-regulated genes are employed in vaccines. In a further embodiment, the identified genes/peptides provide the means for identifying the presence of a mycobacterial infection in a clinical sample by nucleic acid probe or antibody detection.

Claims (27)

1. A vector selected from the group consisting of

(i) a DNA plasmid comprising a promoter, a polyadenylation signal, a selectable marker and a DNA sequence, wherein the promoter and polyadenylation signal are operably linked to the DNA sequence, the promoter is a CMV promoter, the polyadenylation signal is a bovine growth hormone polyadenylation signal, the selectable marker encodes a protein that confers resistance to an antibiotic;

(ii) an RNA vector comprising an isolated RNA sequence that is encoded by the DNA sequence, wherein the RNA vector contains an integration site for a chromosome of a host cell; and

(iii) a viral vector comprising an RNA sequence that is encoded by the DNA sequence;

wherein the DNA sequence is selected from the group consisting of SEQ ID NOs: 40 and 90, or a variant thereof having at least 70% nucleotide sequence identity therewith, or a fragment thereof having at least 15 nucleotides, or a derivative thereof, wherein the peptide encoded by said variant, fragment or derivative has a common antigenic cross-reactivity to the peptide encoded by the DNA sequence;

wherein the DNA sequence is the coding sequence of a M. tuberculosis gene, the expression of which is induced or up-regulated under culture of a mycobacterium under continuous culture conditions defined by a dissolved oxygen tension of up to 10% air saturation measured at 37° C. when compared with a dissolved oxygen tension of at least 40% air saturation measured at 37° C.

2. A viral vector comprising an M. tuberculosis DNA sequence selected from the group consisting of SEQ ID NOs: 40 and 90, or a variant thereof having at least 70% nucleotide sequence identity therewith, or a derivative thereof, wherein the peptide encoded by said variant or derivative has a common antigenic cross-reactivity to the peptide encoded by the DNA sequence;

wherein said M. tuberculosis DNA sequence is the coding sequence of a M. tuberculosis gene, the expression of which is induced or up-regulated during culture of a M. tuberculosis under continuous culture conditions defined by a dissolved oxygen tension of up to 10% air saturation measured at 37° C. when compared with a dissolved oxygen tension of at least 40% air saturation measured at 37° C.

3. A viral vector comprising a DNA sequence, wherein said DNA sequence is:

(i) a fragment of a M. tuberculosis DNA sequence selected from the group consisting of SEQ ID NOs: 40 and 90; wherein said fragment has at least 15 nucleotides;

(ii) a variant of (i) having at least 70% nucleotide sequence identity therewith;

(iii) a fragment of a DNA sequence variant having at least 98% nucleotide sequence identity with the M. tuberculosis DNA sequence SEQ ID NO: 40 or SEQ ID NO: 90, and having a length at least 50% of the length of the M. tuberculosis DNA sequence SEQ ID NOs: 40 or 90 respectively; or

(iv) a derivative of (i), (ii) or (iii);

wherein the peptide encoded by said fragment, variant or derivative has a common antigenic cross-reactivity to the peptide encoded by said M. tuberculosis DNA sequence;

wherein said M. tuberculosis DNA sequence is the coding sequence of a M. tuberculosis gene, the expression of which is induced or up-regulated during culture of M. tuberculosis under continuous culture conditions defined by a dissolved oxygen tension of up to 10% air saturation measured at 37° C. when compared with a dissolved oxygen tension of at least 40% air saturation measured at 37° C.

4. The vector according to claim 1 , wherein the vector is (i) the DNA plasmid.

5. The vector according to claim 1 , wherein the vector is (ii) the RNA vector.

6. The vector according to claim 1 , wherein the vector is (iii) the viral vector.

7. The viral vector according to claim 3 , wherein the DNA sequence is (i) the fragment of the M. tuberculosis DNA sequence.

8. The viral vector according to claim 3 , wherein the DNA sequence is (ii) the variant of (i).

9. The viral vector according to claim 3 , wherein the DNA sequence is (iii) the fragment of the DNA sequence variant.

10. The viral vector according to claim 3 , wherein the DNA sequence is (iv) the derivative of (i), (ii) or (iii).

11. The viral vector according to claim 9 , wherein the length of the DNA fragment is at least 70% of the length of SEQ ID NOs: 40 or 90 respectively.

12. The viral vector according to claim 9 , wherein the length of the DNA fragment is at least 80% of the length of SEQ ID NOs: 40 or 90 respectively.

13. The viral vector according to claim 7 , wherein the length of the fragment is at least 50% of the length of SEQ ID NOs: 40 or 90 respectively.

14. The viral vector according to claim 7 , wherein the length of the fragment is at least 70% of the length of SEQ ID NOs: 40 or 90 respectively.

15. The viral vector according to claim 7 , wherein the length of the fragment is at least 80% of the length of SEQ ID NOs: 40 or 90 respectively.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2013
From: JAMES, BRIAN WILLIAM; BACON, JOANNA; MARSH, PHILIP
To: HEALTH PROTECTION AGENCY
Reel/Frame 031651/0121 →
PROPERTY TRANSFER SCHEME Recorded Nov 21, 2013
From: HEALTH PROTECTION AGENCY
To: THE SECRETARY OF STATE FOR HEALTH
Reel/Frame 031694/0272 →